“Medical data is a bigger goldmine for cyber criminals than credit cards” and “An opt-out scheme for medical data”. Two headlines that recently appeared in ‘Het Financieel Dagblad’ (Dutch financial newspaper). Recently, a lot of attention has been paid to the combination of privacy and medical data. Unfortunately, there are still many misunderstandings as to how these two can go together – in a balanced way – in clinical research and medical studies. And that while the urgency to guarantee the privacy of medical data is only increasing.
In this webinar, especially for life science companies, DPO Consultancy and BG Legal help you to distinguish between facts and fiction about data privacy. The specific challenges for life science companies and the relationship with other legislation related to clinical trials are discussed. Practical tips and tools are also provided to efficiently embed GDPR regulations in the day-to-day processes of your own organization.